Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery for multiple hepatic colorectal metastases.

Norihiro Kokudo1, Hiroshi Imamura, Yasuhiko Sugawara

  • 1Department of Surgery, Hepato-Biliary-Pancreatic Surgery Division, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Journal of Hepato-Biliary-Pancreatic Surgery
|May 6, 2004
PubMed
Summary

Hepatic resection for multiple colorectal metastases is effective, even with four or more tumors. The number of nodules resected should be based on safety and feasibility, as cure is possible.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A Case of 30s Female with Advanced Anal Canal Adenocarcinoma Managed with Adolescent-And-Young-Adult Team].

Gan to kagaku ryoho. Cancer & chemotherapy·2024
Same author

Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study).

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2024
Same author

Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902).

International journal of clinical oncology·2024
Same author

Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer.

International journal of clinical oncology·2024
Same author

Energy Transfer on Cytoskeleton of Red Blood Cell Ghosts and their Efficiency Control by KCl Concentration-induced Cell Shrinkage.

Chemistry (Weinheim an der Bergstrasse, Germany)·2024
Same author

Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal Metastasis.

Annals of surgical oncology·2023

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Colorectal cancer frequently metastasizes to the liver.
  • Hepatic resection is a potential curative treatment for liver metastases.
  • The role of liver resection for multiple colorectal metastases remains debated.

Purpose of the Study:

  • To evaluate the prognostic significance of tumor number in hepatic resection for colorectal metastases.
  • To determine contraindications for hepatic resection based on tumor burden.
  • To establish guidelines for the number of nodules to resect.

Main Methods:

  • Review of institutional data on patients undergoing hepatic resection for colorectal metastases.
  • Analysis of survival outcomes based on the number of liver tumors.

Related Experiment Videos

  • Literature review of reported cases and outcomes.
  • Main Results:

    • The number of tumors is a significant prognostic factor, with worse survival for multiple metastases compared to single metastasis.
    • Survival curves for patients with two to three nodules were similar to those with four or more nodules.
    • Patients with four or more metastases demonstrated comparable or better survival than expected.

    Conclusions:

    • Hepatic resection should be considered for patients with four or more colorectal metastases.
    • The maximum number of resectable nodules is not definitively established and continues to increase in reported cases.
    • Surgery for multiple liver metastases is justified if safe and technically feasible, offering a potential cure.